Clinically Proven: LipoAvail® Boosts NAD+, VC & GSH

Overview


Effepharm

Only few liposomal brands can claim both animal and human clinical validation. While our clinically proven LipoAvail® liposomal series boosts bioavailability: NAD+ by 1.5×, VC by 1.65×, and GSH absorption by 1.38×.

NAD+ supports anti-ageing and metabolism. Our VC & GSH are boost for your skin’s radiance and antioxidant defense —they are all science-backed nutrition solution.

Liposomes encapsulate active ingredients, mimicking cell membranes for better absorption & efficacy.

Download the White Paper to find secrets of Liposomal technology, and discover more clinically backed LipoAvail® products.

This content is paid by Effepharm Ltd, and any views and opinions expressed do not necessarily reflect those of NutraIngredients.com

Download Now


Latest Content

Related Resources

The Global Regulatory Advantage Behind UTHEVER® NMN

The Global Regulatory Advantage Behind UTHEVER® NMN

Paid for by Effepharm Ltd

White Paper

Regulatory uncertainty remains one of the biggest challenges for NMN brands. Choosing the wrong ingredient could lead to compliance risks & market restrictions.

Discover UTHEVER® NMN’s Global Regulatory Landscape

Discover UTHEVER® NMN’s Global Regulatory Landscape

Paid for by Effepharm Ltd

White Paper

NMN has long faced regulatory challenges. Today, that landscape is changing. We consistently invest in scientific research & quality development, aiming to establish UTHEVER® as the world’s most compliant NMN ingredient brand.

Supplier Info Centre

Effepharm-Ltd.jpg

For more product information visit Effepharm Ltd.